| Year |
Citation |
Score |
| 2024 |
Goodwin E, Gibbs JS, Yewdell JW, Eisenlohr LC, Hensley SE. Influenza virus antibodies inhibit antigen-specific B cell responses in mice. Journal of Virology. 98: e0076624. PMID 39194245 DOI: 10.1128/jvi.00766-24 |
0.765 |
|
| 2024 |
Chong EA, Kumashie KG, Chong ER, Fabrizio J, Gupta A, Svoboda J, Barta SK, Walsh KM, Napier EB, Lundberg RK, Nasta SD, Gerson JN, Landsburg DJ, Gonzalez J, Gaano A, ... ... Hensley SE, et al. Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia. The Journal of Infectious Diseases. 230: 15-27. PMID 39052709 DOI: 10.1093/infdis/jiae106 |
0.376 |
|
| 2024 |
Cowling BJ, Wong SS, Santos JJS, Touyon L, Ort JT, Ye N, Kwok NKM, Ho F, Cheng SMS, Ip DKM, Peiris M, Webby RJ, Wilson PC, Valkenburg SA, Tsang JS, ... ... Hensley SE, et al. Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 39041887 DOI: 10.1093/cid/ciae380 |
0.373 |
|
| 2024 |
Anderson AR, Strouse JJ, Manwani D, Brandow AM, Vichinsky EP, Campbell A, Leavey PJ, Nero A, Ibrahim IF, Field JJ, Baer A, Soto-Calderon H, Vincent L, Zhao Y, Santos JJS, ... Hensley SE, et al. COVID-19 mRNA Vaccination Responses in Individuals With Sickle Cell Disease: ASH RC Sickle Cell Research Network Study. Blood Advances. PMID 38991137 DOI: 10.1182/bloodadvances.2024013878 |
0.346 |
|
| 2024 |
England RN, Drapeau EM, Alameh MG, Hosseinzadeh R, Weissman D, Hensley SE. Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model. Npj Vaccines. 9: 110. PMID 38890316 DOI: 10.1038/s41541-024-00901-4 |
0.397 |
|
| 2024 |
Sobel Leonard A, Mendoza L, McFarland AG, Marques AD, Everett JK, Moncla L, Bushman FD, Odom John AR, Hensley SE. Within-host influenza viral diversity in the pediatric population as a function of age, vaccine, and health status. Virus Evolution. 10: veae034. PMID 38859985 DOI: 10.1093/ve/veae034 |
0.439 |
|
| 2024 |
Dadonaite B, Ahn JJ, Ort JT, Yu J, Furey C, Dosey A, Hannon WW, Baker AV, Webby RJ, King NP, Liu Y, Hensley SE, Peacock TP, Moncla LH, Bloom JD. Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillance. Biorxiv : the Preprint Server For Biology. PMID 38826368 DOI: 10.1101/2024.05.23.595634 |
0.336 |
|
| 2024 |
Cowling BJ, Wong SS, Santos JJS, Touyon L, Ort J, Ye N, Kwok NKM, Ho F, Cheng SMS, Ip DKM, Peiris M, Webby RJ, Wilson PC, Valkenburg SA, Tsang JS, ... ... Hensley SE, et al. Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled Trial. Medrxiv : the Preprint Server For Health Sciences. PMID 38798684 DOI: 10.1101/2024.05.16.24307455 |
0.39 |
|
| 2024 |
Furey C, Scher G, Ye N, Kercher L, DeBeauchamp J, Crumpton JC, Jeevan T, Patton C, Franks J, Rubrum A, Alameh MG, Fan SHY, Phan AT, Hunter CA, Webby RJ, ... ... Hensley SE, et al. Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus. Nature Communications. 15: 4350. PMID 38782954 DOI: 10.1038/s41467-024-48555-z |
0.433 |
|
| 2024 |
Goodwin E, Gibbs JS, Yewdell JW, Eisenlohr LC, Hensley SE. Influenza virus antibodies inhibit antigen-specific B cell responses in mice. Biorxiv : the Preprint Server For Biology. PMID 38659819 DOI: 10.1101/2024.04.12.589218 |
0.764 |
|
| 2024 |
Johnston TS, Li SH, Painter MM, Atkinson RK, Douek NR, Reeg DB, Douek DC, Wherry EJ, Hensley SE. Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants. Immunity. PMID 38490198 DOI: 10.1016/j.immuni.2024.02.017 |
0.395 |
|
| 2024 |
Chong EA, Kumashie KG, Chong ER, Fabrizio J, Gupta A, Svoboda J, Barta SK, Walsh KM, Napier EB, Lundberg RK, Nasta SD, Gerson JN, Landsburg DJ, Gonzalez J, Gaano A, ... ... Hensley SE, et al. Immunologic predictors of vaccine responsiveness in patients with lymphoma and CLL. The Journal of Infectious Diseases. PMID 38437622 DOI: 10.1093/infdis/jiae106 |
0.346 |
|
| 2024 |
Johnston TS, Li SH, Painter MM, Atkinson RK, Douek NR, Reeg DB, Douek DC, Wherry EJ, Hensley SE. Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants. Medrxiv : the Preprint Server For Health Sciences. PMID 38260304 DOI: 10.1101/2024.01.08.24301002 |
0.415 |
|
| 2023 |
Kim K, Gouma S, Vieira MC, Weirick ME, Hensley SE, Cobey S. Measures of population immunity can predict the dominant clade of influenza A (H3N2) and reveal age-associated differences in susceptibility and specificity. Medrxiv : the Preprint Server For Health Sciences. PMID 37961288 DOI: 10.1101/2023.10.26.23297569 |
0.395 |
|
| 2023 |
Painter MM, Johnston TS, Lundgreen KA, Santos JJS, Qin JS, Goel RR, Apostolidis SA, Mathew D, Fulmer B, Williams JC, McKeague ML, Pattekar A, Goode A, Nasta S, Baxter AE, ... ... Hensley SE, et al. Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection. Nature Immunology. PMID 37735592 DOI: 10.1038/s41590-023-01613-y |
0.72 |
|
| 2023 |
Bolton MJ, Santos JJS, Arevalo CP, Griesman T, Watson M, Li SH, Bates P, Ramage H, Wilson PC, Hensley SE. IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding. Proceedings of the National Academy of Sciences of the United States of America. 120: e2216521120. PMID 37603748 DOI: 10.1073/pnas.2216521120 |
0.728 |
|
| 2023 |
Furey C, Ye N, Kercher L, DeBeauchamp J, Crumpton JC, Jeevan T, Patton C, Franks J, Alameh MG, Fan SHY, Phan AT, Hunter CA, Webby RJ, Weissman D, Hensley SE. Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus. Biorxiv : the Preprint Server For Biology. PMID 37162920 DOI: 10.1101/2023.04.30.538854 |
0.395 |
|
| 2023 |
Painter MM, Johnston TS, Lundgreen KA, Santos JJS, Qin JS, Goel RR, Apostolidis SA, Mathew D, Fulmer B, Williams JC, McKeague ML, Pattekar A, Goode A, Nasta S, Baxter AE, ... ... Hensley SE, et al. Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies. Biorxiv : the Preprint Server For Biology. PMID 36798171 DOI: 10.1101/2023.02.05.527215 |
0.725 |
|
| 2022 |
Gouma S, Furey C, Santos JJS, Parkhouse K, Weirick M, Muramatsu H, Pardi N, Fan SHY, Weissman D, Hensley SE. Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation. Journal of Virology. e0172322. PMID 36533954 DOI: 10.1128/jvi.01723-22 |
0.732 |
|
| 2022 |
Arevalo CP, Bolton MJ, Le Sage V, Ye N, Furey C, Muramatsu H, Alameh MG, Pardi N, Drapeau EM, Parkhouse K, Garretson T, Morris JS, Moncla LH, Tam YK, Fan SHY, ... ... Hensley SE, et al. A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes. Science (New York, N.Y.). 378: 899-904. PMID 36423275 DOI: 10.1126/science.abm0271 |
0.495 |
|
| 2022 |
Flannery DD, Gouma S, Dhudasia MB, Mukhopadhyay S, Pfeifer MR, Woodford EC, Briker SM, Triebwasser JE, Gerber JS, Morris JS, Weirick ME, McAllister CM, Hensley SE, Puopolo KM. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection. Jama Network Open. 5: e2240993. PMID 36350652 DOI: 10.1001/jamanetworkopen.2022.40993 |
0.303 |
|
| 2022 |
Anderson EM, Li SH, Awofolaju M, Eilola T, Goodwin E, Bolton MJ, Gouma S, Manzoni TB, Hicks P, Goel RR, Painter MM, Apostolidis SA, Mathew D, Dunbar D, Fiore D, ... ... Hensley SE, et al. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations. Cell Reports. 41: 111496. PMID 36261003 DOI: 10.1016/j.celrep.2022.111496 |
0.405 |
|
| 2022 |
Bolton MJ, Arevalo CP, Griesman T, Li SH, Bates P, Wilson PC, Hensley SE. IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding. Biorxiv : the Preprint Server For Biology. PMID 36203556 DOI: 10.1101/2022.09.27.509738 |
0.431 |
|
| 2022 |
Lyudovyk O, Kim JY, Qualls D, Hwee MA, Lin YH, Boutemine SR, Elhanati Y, Solovyov A, Douglas M, Chen E, Babady NE, Ramanathan L, Vedantam P, Bandlamudi C, Gouma S, ... ... Hensley SE, et al. Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses. Cancer Cell. PMID 35679859 DOI: 10.1016/j.ccell.2022.05.013 |
0.312 |
|
| 2022 |
Bolton MJ, Ort JT, McBride R, Swanson NJ, Wilson J, Awofolaju M, Furey C, Greenplate AR, Drapeau EM, Pekosz A, Paulson JC, Hensley SE. Antigenic and virological properties of an H3N2 variant that continues to dominate the 2021-22 Northern Hemisphere influenza season. Cell Reports. 39: 110897. PMID 35649381 DOI: 10.1016/j.celrep.2022.110897 |
0.448 |
|
| 2022 |
Christensen SR, Martin ET, Petrie JG, Monto AS, Hensley SE. The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade. Journal of Virology. e0220021. PMID 35588275 DOI: 10.1128/jvi.02200-21 |
0.424 |
|
| 2022 |
Goel RR, Painter MM, Lundgreen KA, Apostolidis SA, Baxter AE, Giles JR, Mathew D, Pattekar A, Reynaldi A, Khoury DS, Gouma S, Hicks P, Dysinger S, Hicks A, Sharma H, ... ... Hensley SE, et al. Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine. Cell. PMID 35523182 DOI: 10.1016/j.cell.2022.04.009 |
0.371 |
|
| 2022 |
Goel RR, Painter MM, Lundgreen KA, Apostolidis SA, Baxter AE, Giles JR, Mathew D, Pattekar A, Reynaldi A, Khoury DS, Gouma S, Hicks P, Dysinger S, Hicks A, Sharma H, ... ... Hensley SE, et al. Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine. Biorxiv : the Preprint Server For Biology. PMID 35233575 DOI: 10.1101/2022.02.20.481163 |
0.364 |
|
| 2022 |
Lederer K, Bettini E, Parvathaneni K, Painter MM, Agarwal D, Lundgreen KA, Weirick M, Muralidharan K, Castaño D, Goel RR, Xu X, Drapeau EM, Gouma S, Ort JT, Awofolaju M, ... ... Hensley SE, et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Cell. PMID 35202565 DOI: 10.1016/j.cell.2022.01.027 |
0.407 |
|
| 2021 |
Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng W, Rosenfeld AM, Lundgreen KA, Reynaldi A, Khoury DS, Pattekar A, Gouma S, Kuri-Cervantes L, Hicks P, Dysinger S, Hicks A, ... ... Hensley SE, et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science (New York, N.Y.). eabm0829. PMID 34648302 DOI: 10.1126/science.abm0829 |
0.414 |
|
| 2021 |
Lederer K, Parvathaneni K, Painter MM, Bettini E, Agarwal D, Lundgreen KA, Weirick M, Goel RR, Xu X, Drapeau EM, Gouma S, Greenplate AR, Coz CL, Romberg N, Jones L, ... ... Hensley SE, et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Medrxiv : the Preprint Server For Health Sciences. PMID 34580676 DOI: 10.1101/2021.09.16.21263686 |
0.405 |
|
| 2021 |
Apostolidis SA, Kakara M, Painter MM, Goel RR, Mathew D, Lenzi K, Rezk A, Patterson KR, Espinoza DA, Kadri JC, Markowitz DM, E Markowitz C, Mexhitaj I, Jacobs D, Babb A, ... ... Hensley SE, et al. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy. Nature Medicine. PMID 34522051 DOI: 10.1038/s41591-021-01507-2 |
0.405 |
|
| 2021 |
Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng W, Rosenfeld AM, Lundgreen KA, Reynaldi A, Khoury DS, Pattekar A, Gouma S, Kuri-Cervantes L, Hicks P, Dysinger S, Hicks A, ... ... Hensley SE, et al. mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern. Biorxiv : the Preprint Server For Biology. PMID 34462751 DOI: 10.1101/2021.08.23.457229 |
0.424 |
|
| 2021 |
Painter MM, Mathew D, Goel RR, Apostolidis SA, Pattekar A, Kuthuru O, Baxter AE, Herati RS, Oldridge DA, Gouma S, Hicks P, Dysinger S, Lundgreen KA, Kuri-Cervantes L, Adamski S, ... ... Hensley SE, et al. Rapid induction of antigen-specific CD4 T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination. Immunity. PMID 34453880 DOI: 10.1016/j.immuni.2021.08.001 |
0.397 |
|
| 2021 |
Guthmiller JJ, Utset HA, Henry C, Li L, Zheng NY, Sun W, Costa Vieira M, Zost S, Huang M, Hensley SE, Cobey S, Palese P, Wilson PC. An Egg-Derived Sulfated -Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines. Mbio. e0083821. PMID 34126773 DOI: 10.1128/mBio.00838-21 |
0.488 |
|
| 2021 |
Pan YG, Aiamkitsumrit B, Bartolo L, Wang Y, Lavery C, Marc A, Holec PV, Rappazzo CG, Eilola T, Gimotty PA, Hensley SE, Antia R, Zarnitsyna VI, Birnbaum ME, Su LF. Vaccination reshapes the virus-specific T cell repertoire in unexposed adults. Immunity. PMID 34004140 DOI: 10.1016/j.immuni.2021.04.023 |
0.407 |
|
| 2021 |
Goel RR, Apostolidis SA, Painter MM, Mathew D, Pattekar A, Kuthuru O, Gouma S, Hicks P, Meng W, Rosenfeld AM, Dysinger S, Lundgreen KA, Kuri-Cervantes L, Adamski S, Hicks A, ... ... Hensley SE, et al. Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination. Science Immunology. 6. PMID 33858945 DOI: 10.1126/sciimmunol.abi6950 |
0.391 |
|
| 2021 |
Goel RR, Apostolidis SA, Painter MM, Mathew D, Pattekar A, Kuthuru O, Gouma S, Kuri-Cervantes L, Meng W, Adamski S, Baxter AE, Giles JR, Weirick ME, McAllister CM, Hicks A, ... ... Hensley SE, et al. Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination. Medrxiv : the Preprint Server For Health Sciences. PMID 33688691 DOI: 10.1101/2021.03.03.21252872 |
0.398 |
|
| 2021 |
Anderson EM, Goodwin EC, Verma A, Arevalo CP, Bolton MJ, Weirick ME, Gouma S, McAllister CM, Christensen SR, Weaver J, Hicks P, Manzoni TB, Oniyide O, Ramage H, Mathew D, ... ... Hensley SE, et al. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Cell. PMID 33631096 DOI: 10.1016/j.cell.2021.02.010 |
0.312 |
|
| 2021 |
Le Sage V, Jones JE, Kormuth KA, Fitzsimmons WJ, Nturibi E, Padovani GH, Arevalo CP, French AJ, Avery AJ, Manivanh R, McGrady EE, Bhagwat AR, Lauring AS, Hensley SE, Lakdawala SS. Pre-existing heterosubtypic immunity provides a barrier to airborne transmission of influenza viruses. Plos Pathogens. 17: e1009273. PMID 33600489 DOI: 10.1371/journal.ppat.1009273 |
0.433 |
|
| 2020 |
Diorio C, McNerney KO, Lambert M, Paessler M, Anderson EM, Henrickson SE, Chase J, Liebling EJ, Burudpakdee C, Lee JH, Balamuth FB, Blatz AM, Chiotos K, Fitzgerald JC, Giglia TM, ... ... Hensley SE, et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Advances. 4: 6051-6063. PMID 33290544 DOI: 10.1182/bloodadvances.2020003471 |
0.43 |
|
| 2020 |
Anderson EM, Goodwin EC, Verma A, Arevalo CP, Bolton MJ, Weirick ME, Gouma S, McAllister CM, Christensen SR, Weaver J, Hicks P, Manzoni TB, Oniyide O, Ramage H, Mathew D, ... ... Hensley SE, et al. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Medrxiv : the Preprint Server For Health Sciences. PMID 33200143 DOI: 10.1101/2020.11.06.20227215 |
0.31 |
|
| 2020 |
Rahil Z, Leylek R, Schürch CM, Chen H, Bjornson-Hooper Z, Christensen SR, Gherardini PF, Bhate SS, Spitzer MH, Fragiadakis GK, Mukherjee N, Kim N, Jiang S, Yo J, Gaudilliere B, ... ... Hensley SE, et al. Landscape of coordinated immune responses to H1N1 challenge in humans. The Journal of Clinical Investigation. PMID 33044226 DOI: 10.1172/JCI137265 |
0.428 |
|
| 2020 |
Gouma S, Kim K, Weirick ME, Gumina ME, Branche A, Topham DJ, Martin ET, Monto AS, Cobey S, Hensley SE. Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility. Nature Communications. 11: 4566. PMID 32917903 DOI: 10.1038/S41467-020-18465-X |
0.511 |
|
| 2020 |
Diorio C, Anderson EM, McNerney KO, Goodwin EC, Chase JC, Bolton MJ, Arevalo CP, Weirick ME, Gouma S, Vella LA, Henrickson SE, Chiotos K, Fitzgerald JC, Kilbaugh TJ, John ARO, ... ... Hensley SE, et al. Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome. Pediatric Blood & Cancer. e28693. PMID 32885904 DOI: 10.1002/Pbc.28693 |
0.536 |
|
| 2020 |
Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, Kuri-Cervantes L, Pampena MB, D'Andrea K, Manne S, Chen Z, Huang YJ, Reilly JP, Weisman AR, ... ... Hensley SE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science (New York, N.Y.). PMID 32669297 DOI: 10.1126/Science.Abc8511 |
0.462 |
|
| 2020 |
Kuri-Cervantes L, Pampena MB, Meng W, Rosenfeld AM, Ittner CAG, Weisman AR, Agyekum RS, Mathew D, Baxter AE, Vella LA, Kuthuru O, Apostolidis SA, Bershaw L, Dougherty J, Greenplate AR, ... ... Hensley SE, et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Science Immunology. 5. PMID 32669287 DOI: 10.1126/Sciimmunol.Abd7114 |
0.369 |
|
| 2020 |
Arevalo CP, Le Sage V, Bolton MJ, Eilola T, Jones JE, Kormuth KA, Nturibi E, Balmaseda A, Gordon A, Lakdawala SS, Hensley SE. Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies. Proceedings of the National Academy of Sciences of the United States of America. PMID 32631992 DOI: 10.1073/Pnas.1920321117 |
0.576 |
|
| 2020 |
Mathew D, Giles JR, Baxter AE, Greenplate AR, Wu JE, Alanio C, Oldridge DA, Kuri-Cervantes L, Pampena MB, D'Andrea K, Manne S, Chen Z, Huang YJ, Reilly JP, Weisman AR, ... ... Hensley SE, et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. Biorxiv : the Preprint Server For Biology. PMID 32511371 DOI: 10.1101/2020.05.20.106401 |
0.312 |
|
| 2020 |
Gouma S, Weirick M, Hensley SE. Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine. Nature Communications. 11: 2445. PMID 32415074 DOI: 10.1038/S41467-020-16183-Y |
0.498 |
|
| 2020 |
Gouma S, Anderson EM, Hensley SE. Challenges of Making Effective Influenza Vaccines. Annual Review of Virology. PMID 32392457 DOI: 10.1146/Annurev-Virology-010320-044746 |
0.493 |
|
| 2020 |
Johnson JL, Rosenthal RL, Knox JJ, Myles A, Naradikian MS, Madej J, Kostiv M, Rosenfeld AM, Meng W, Christensen SR, Hensley SE, Yewdell J, Canaday DH, Zhu J, McDermott AB, et al. The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans. Immunity. PMID 32353250 DOI: 10.1016/J.Immuni.2020.03.020 |
0.574 |
|
| 2020 |
Worobey M, Plotkin S, Hensley SE. Influenza Vaccines Delivered in Early Childhood Could Turn Antigenic Sin into Antigenic Blessings. Cold Spring Harbor Perspectives in Medicine. PMID 31964642 DOI: 10.1101/Cshperspect.A038471 |
0.552 |
|
| 2020 |
Willis E, Pardi N, Parkhouse K, Mui BL, Tam YK, Weissman D, Hensley SE. Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice. Science Translational Medicine. 12. PMID 31915303 DOI: 10.1126/Scitranslmed.Aav5701 |
0.552 |
|
| 2019 |
Zost SJ, Lee J, Gumina ME, Parkhouse K, Henry C, Wu NC, Lee CD, Wilson IA, Wilson PC, Bloom JD, Hensley SE. Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans. Cell Reports. 29: 4460-4470.e8. PMID 31875553 DOI: 10.1016/J.Celrep.2019.11.084 |
0.526 |
|
| 2019 |
Gouma S, Zost SJ, Parkhouse K, Branche A, Topham DJ, Cobey S, Hensley SE. Comparison of human H3N2 antibody responses elicited by egg-based, cell-based, and recombinant protein-based influenza vaccines during the 2017-2018 season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31598646 DOI: 10.1093/Cid/Ciz996 |
0.537 |
|
| 2019 |
Lee JM, Eguia R, Zost SJ, Choudhary S, Wilson PC, Bedford T, Stevens-Ayers T, Boeckh M, Hurt AC, Lakdawala SS, Hensley SE, Bloom JD. Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin. Elife. 8. PMID 31452511 DOI: 10.7554/Elife.49324 |
0.458 |
|
| 2019 |
Gouma S, Weirick M, Hensley SE. Potential antigenic mismatch of the H3N2 component of the 2019 Southern Hemisphere influenza vaccine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31400756 DOI: 10.1093/Cid/Ciz723 |
0.555 |
|
| 2019 |
Altman MO, Angel M, Košík I, Trovão NS, Zost SJ, Gibbs JS, Casalino L, Amaro RE, Hensley SE, Nelson MI, Yewdell JW. Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit. Mbio. 10. PMID 30940704 DOI: 10.1128/Mbio.00204-19 |
0.663 |
|
| 2019 |
Henry C, Zheng NY, Huang M, Cabanov A, Rojas KT, Kaur K, Andrews SF, Palm AE, Chen YQ, Li Y, Hoskova K, Utset HA, Vieira MC, Wrammert J, Ahmed R, ... ... Hensley SE, et al. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. Cell Host & Microbe. PMID 30795982 DOI: 10.1016/J.Chom.2019.01.002 |
0.706 |
|
| 2019 |
Christensen SR, Toulmin SA, Griesman T, Lamerato LE, Petrie JG, Martin ET, Monto AS, Hensley SE. Assessing the protective potential of H1N1 influenza virus hemagglutinin head and stalk antibodies in humans. Journal of Virology. PMID 30700610 DOI: 10.1128/Jvi.02134-18 |
0.533 |
|
| 2019 |
Lee JM, Eguia R, Zost SJ, Choudhary S, Wilson PC, Bedford T, Stevens-Ayers T, Boeckh M, Hurt AC, Lakdawala SS, Hensley SE, Bloom JD. Author response: Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin Elife. DOI: 10.7554/Elife.49324.049 |
0.366 |
|
| 2019 |
Henrickson SE, Bengsch B, O'Boyle KC, Manne S, Herati RS, Vella LA, Hensley SE, Rabinowitz JR, Coffin SE, Wherry EJ. OBESITY DYSREGULATES IMMUNOMETABOLIC STATUS IN ASTHMA AND IMPACTS VACCINE RESPONSES Journal of Allergy and Clinical Immunology. 143: AB306. DOI: 10.1016/J.Jaci.2018.12.934 |
0.338 |
|
| 2018 |
Zost SJ, Wu NC, Hensley SE, Wilson IA. Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens. The Journal of Infectious Diseases. PMID 30535315 DOI: 10.1093/Infdis/Jiy696 |
0.578 |
|
| 2018 |
Pardi N, Parkhouse K, Kirkpatrick E, McMahon M, Zost SJ, Mui BL, Tam YK, Karikó K, Barbosa CJ, Madden TD, Hope MJ, Krammer F, Hensley SE, Weissman D. Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies. Nature Communications. 9: 3361. PMID 30135514 DOI: 10.1038/S41467-018-05482-0 |
0.588 |
|
| 2018 |
Davis AKF, McCormick K, Gumina ME, Petrie JG, Martin ET, Xue KS, Bloom JD, Monto AS, Bushman FD, Hensley SE. Sera from individuals with narrowly focused influenza virus antibodies rapidly select viral escape mutations . Journal of Virology. PMID 30045982 DOI: 10.1128/Jvi.00859-18 |
0.548 |
|
| 2018 |
Garretson TA, Petrie JG, Martin ET, Monto AS, Hensley SE. Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain. Vaccine. PMID 29861178 DOI: 10.1016/J.Vaccine.2018.05.086 |
0.538 |
|
| 2018 |
Jain S, George PJ, Deng W, Koussa J, Parkhouse K, Hensley SE, Jiang J, Lu J, Liu Z, Wei J, Zhan B, Bottazzi ME, Shen H, Lustigman S. The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4 T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway. Vaccine. PMID 29764680 DOI: 10.1016/J.Vaccine.2018.05.029 |
0.575 |
|
| 2018 |
Pardi N, Hogan MJ, Naradikian MS, Parkhouse K, Cain DW, Jones L, Moody MA, Verkerke HP, Myles A, Willis E, LaBranche CC, Montefiori DC, Lobby JL, Saunders KO, Liao HX, ... ... Hensley SE, et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. The Journal of Experimental Medicine. PMID 29739835 DOI: 10.1084/Jem.20171450 |
0.724 |
|
| 2018 |
Cobey S, Gouma S, Parkhouse K, Chambers BS, Ertl HC, Schmader KE, Halpin RA, Lin X, Stockwell TB, Das SR, Landon E, Tesic V, Youngster I, Pinsky BA, Wentworth DE, ... Hensley SE, et al. Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29471464 DOI: 10.1093/Cid/Ciy097 |
0.707 |
|
| 2018 |
Henrickson SE, Manne S, Dolfi DV, Mansfield KD, Parkhouse K, Mistry RD, Alpern ER, Hensley SE, Sullivan KE, Coffin SE, Wherry EJ. Genomic Circuitry Underlying Immunological Response to Pediatric Acute Respiratory Infection. Cell Reports. 22: 411-426. PMID 29320737 DOI: 10.1016/J.Celrep.2017.12.043 |
0.426 |
|
| 2017 |
Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proceedings of the National Academy of Sciences of the United States of America. PMID 29109276 DOI: 10.1073/Pnas.1712377114 |
0.561 |
|
| 2017 |
Wu NC, Zost SJ, Thompson AJ, Oyen D, Nycholat CM, McBride R, Paulson JC, Hensley SE, Wilson IA. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. Plos Pathogens. 13: e1006682. PMID 29059230 DOI: 10.1371/Journal.Ppat.1006682 |
0.548 |
|
| 2017 |
Herati RS, Muselman A, Vella L, Bengsch B, Parkhouse K, Del Alcazar D, Kotzin J, Doyle SA, Tebas P, Hensley SE, Su LF, Schmader KE, Wherry EJ. Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells. Science Immunology. 2. PMID 28620653 DOI: 10.1126/Sciimmunol.Aag2152 |
0.483 |
|
| 2017 |
Willis E, Hensley SE. Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies. Virology. 508: 1-6. PMID 28475924 DOI: 10.1016/J.Virol.2017.04.031 |
0.458 |
|
| 2017 |
Doud MB, Hensley SE, Bloom JD. Complete mapping of viral escape from neutralizing antibodies. Plos Pathogens. 13: e1006271. PMID 28288189 DOI: 10.1371/Journal.Ppat.1006271 |
0.428 |
|
| 2017 |
Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, Wagner W, Granados A, Greenhouse J, Walker M, Willis E, ... ... Hensley SE, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. PMID 28151488 DOI: 10.1038/Nature21428 |
0.492 |
|
| 2017 |
Cobey S, Hensley SE. Immune history and influenza virus susceptibility. Current Opinion in Virology. 22: 105-111. PMID 28088686 DOI: 10.1016/J.Coviro.2016.12.004 |
0.583 |
|
| 2016 |
Petrie JG, Parkhouse K, Ohmit SE, Malosh RE, Monto AS, Hensley SE. Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains. The Journal of Infectious Diseases. 214: 1947-1951. PMID 27923954 DOI: 10.1093/Infdis/Jiw479 |
0.513 |
|
| 2016 |
Willis E, Parkhouse K, Krammer F, Hensley SE. Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States. Vaccine. PMID 27670073 DOI: 10.1016/J.Vaccine.2016.09.017 |
0.54 |
|
| 2016 |
Linderman SL, Hensley SE. Antibodies with 'Original Antigenic Sin' Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses. Plos Pathogens. 12: e1005806. PMID 27537358 DOI: 10.1371/Journal.Ppat.1005806 |
0.538 |
|
| 2016 |
Naradikian MS, Myles A, Beiting DP, Roberts KJ, Dawson L, Herati RS, Bengsch B, Linderman SL, Stelekati E, Spolski R, Wherry EJ, Hunter C, Hensley SE, Leonard WJ, Cancro MP. Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 27430719 DOI: 10.4049/Jimmunol.1600522 |
0.348 |
|
| 2016 |
Xue J, Chambers BS, Hensley SE, López CB. Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin Mutations. Frontiers in Microbiology. 7: 326. PMID 27047455 DOI: 10.3389/Fmicb.2016.00326 |
0.487 |
|
| 2015 |
Chambers BS, Parkhouse K, Ross TM, Alby K, Hensley SE. Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. Cell Reports. 12: 1-6. PMID 26119736 DOI: 10.1016/J.Celrep.2015.06.005 |
0.552 |
|
| 2015 |
Scott VL, Patel A, Villarreal DO, Hensley SE, Ragwan E, Yan J, Sardesai NY, Rothwell PJ, Extance JP, Caproni LJ, Weiner DB. Novel synthetic plasmid and doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice. Human Vaccines & Immunotherapeutics. 0. PMID 26091432 DOI: 10.1080/21645515.2015.1022008 |
0.513 |
|
| 2015 |
Hackett BA, Yasunaga A, Panda D, Tartell MA, Hopkins KC, Hensley SE, Cherry S. RNASEK is required for internalization of diverse acid-dependent viruses. Proceedings of the National Academy of Sciences of the United States of America. 112: 7797-802. PMID 26056282 DOI: 10.1073/Pnas.1424098112 |
0.415 |
|
| 2014 |
Deng Z, Kim ET, Vladimirova O, Dheekollu J, Wang Z, Newhart A, Liu D, Myers JL, Hensley SE, Moffat J, Janicki SM, Fraser NW, Knipe DM, Weitzman MD, Lieberman PM. HSV-1 remodels host telomeres to facilitate viral replication. Cell Reports. 9: 2263-78. PMID 25497088 DOI: 10.1016/J.Celrep.2014.11.019 |
0.313 |
|
| 2014 |
Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, Ellebedy AH, Carter DM, Andrews SF, Zheng NY, Huang M, Huang Y, Strauss D, Shaz BH, Hodinka RL, ... ... Hensley SE, et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proceedings of the National Academy of Sciences of the United States of America. 111: 15798-803. PMID 25331901 DOI: 10.1073/Pnas.1409171111 |
0.508 |
|
| 2014 |
Brockhurst MA, Hensley SE. Editorial overview: viral evolution: exploring the frontiers of virus evolution in the lab, the field and the clinic. Current Opinion in Virology. 8: ix-x. PMID 25224393 DOI: 10.1016/J.Coviro.2014.09.002 |
0.354 |
|
| 2014 |
Hensley SE. Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Current Opinion in Virology. 8: 85-9. PMID 25108824 DOI: 10.1016/J.Coviro.2014.07.007 |
0.522 |
|
| 2014 |
Wolf AI, Strauman MC, Mozdzanowska K, Whittle JR, Williams KL, Sharpe AH, Weiser JN, Caton AJ, Hensley SE, Erikson J. Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus. Journal of Virology. 88: 11995-2005. PMID 25100838 DOI: 10.1128/Jvi.01833-14 |
0.557 |
|
| 2014 |
Wolf AI, Strauman MC, Mozdzanowska K, Williams KL, Osborne LC, Shen H, Liu Q, Garlick D, Artis D, Hensley SE, Caton AJ, Weiser JN, Erikson J. Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease. Virology. 462: 254-65. PMID 24999050 DOI: 10.1016/J.Virol.2014.06.019 |
0.435 |
|
| 2014 |
Chambers BS, Li Y, Hodinka RL, Hensley SE. Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. Journal of Virology. 88: 10986-9. PMID 24991002 DOI: 10.1128/Jvi.01077-14 |
0.494 |
|
| 2014 |
Jiang J, Fisher EM, Hensley SE, Lustigman S, Murasko DM, Shen H. Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines. Vaccine. 32: 2696-702. PMID 24681229 DOI: 10.1016/J.Vaccine.2014.03.046 |
0.551 |
|
| 2013 |
Myers JL, Wetzel KS, Linderman SL, Li Y, Sullivan CB, Hensley SE. Compensatory hemagglutinin mutations alter antigenic properties of influenza viruses. Journal of Virology. 87: 11168-72. PMID 23926344 DOI: 10.1128/Jvi.01414-13 |
0.431 |
|
| 2013 |
Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, Principi N, Plotkin JB, Ross TM, Ahmed R, Wilson PC, ... Hensley SE, et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. The Journal of Experimental Medicine. 210: 1493-500. PMID 23857983 DOI: 10.1084/Jem.20130212 |
0.534 |
|
| 2013 |
Li Y, Bostick DL, Sullivan CB, Myers JL, Griesemer SB, Stgeorge K, Plotkin JB, Hensley SE. Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering. Journal of Virology. 87: 9904-10. PMID 23824816 DOI: 10.1128/Jvi.01023-13 |
0.515 |
|
| 2013 |
Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW. Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host & Microbe. 13: 314-23. PMID 23498956 DOI: 10.1016/J.Chom.2013.02.008 |
0.727 |
|
| 2011 |
Das SR, Hensley SE, David A, Schmidt L, Gibbs JS, Puigbò P, Ince WL, Bennink JR, Yewdell JW. Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proceedings of the National Academy of Sciences of the United States of America. 108: E1417-22. PMID 22106257 DOI: 10.1073/Pnas.1108754108 |
0.797 |
|
| 2011 |
Myers JL, Hensley SE. Oseltamivir-resistant influenza viruses get by with a little help from permissive mutations. Expert Review of Anti-Infective Therapy. 9: 385-8. PMID 21504394 DOI: 10.1586/Eri.11.2 |
0.408 |
|
| 2011 |
Hensley SE, Das SR, Gibbs JS, Bailey AL, Schmidt LM, Bennink JR, Yewdell JW. Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. Plos One. 6: e15190. PMID 21364978 DOI: 10.1371/Journal.Pone.0015190 |
0.687 |
|
| 2010 |
Das SR, Puigbò P, Hensley SE, Hurt DE, Bennink JR, Yewdell JW. Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. Plos Pathogens. 6: e1001211. PMID 21124818 DOI: 10.1371/Journal.Ppat.1001211 |
0.723 |
|
| 2010 |
Hensley SE, Zanker D, Dolan BP, David A, Hickman HD, Embry AC, Skon CN, Grebe KM, Griffin TA, Chen W, Bennink JR, Yewdell JW. Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. Journal of Immunology (Baltimore, Md. : 1950). 184: 4115-22. PMID 20228196 DOI: 10.4049/Jimmunol.0903003 |
0.74 |
|
| 2009 |
Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, Viswanathan K, Raman R, Sasisekharan R, Bennink JR, Yewdell JW. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science (New York, N.Y.). 326: 734-6. PMID 19900932 DOI: 10.1126/Science.1178258 |
0.748 |
|
| 2009 |
Hensley SE, Yewdell JW. Que sera, sera: evolution of the swine H1N1 influenza A virus. Expert Review of Anti-Infective Therapy. 7: 763-8. PMID 19735217 DOI: 10.1586/Eri.09.62 |
0.622 |
|
| 2009 |
Hensley SE, Pinto AK, Hickman HD, Kastenmayer RJ, Bennink JR, Virgin HW, Yewdell JW. Murine norovirus infection has no significant effect on adaptive immunity to vaccinia virus or influenza A virus. Journal of Virology. 83: 7357-60. PMID 19403665 DOI: 10.1128/Jvi.00623-09 |
0.628 |
|
| 2009 |
Pichla-Gollon SL, Lin SW, Hensley SE, Lasaro MO, Herkenhoff-Haut L, Drinker M, Tatsis N, Gao GP, Wilson JM, Ertl HC, Bergelson JM. Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo. Journal of Virology. 83: 5567-73. PMID 19279092 DOI: 10.1128/Jvi.00405-09 |
0.652 |
|
| 2009 |
Wolf AI, Buehler D, Hensley SE, Cavanagh LL, Wherry EJ, Kastner P, Chan S, Weninger W. Plasmacytoid dendritic cells are dispensable during primary influenza virus infection. Journal of Immunology (Baltimore, Md. : 1950). 182: 871-9. PMID 19124730 DOI: 10.4049/Jimmunol.182.2.871 |
0.491 |
|
| 2008 |
Lasaro MO, Tatsis N, Hensley SE, Whitbeck JC, Lin SW, Rux JJ, Wherry EJ, Cohen GH, Eisenberg RJ, Ertl HC. Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses. Nature Medicine. 14: 205-12. PMID 18193057 DOI: 10.1038/Nm1704 |
0.64 |
|
| 2008 |
Hickman HD, Takeda K, Skon CN, Murray FR, Hensley SE, Loomis J, Barber GN, Bennink JR, Yewdell JW. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nature Immunology. 9: 155-65. PMID 18193049 DOI: 10.1038/Ni1557 |
0.555 |
|
| 2008 |
Iparraguirre A, Tobias JW, Hensley SE, Masek KS, Cavanagh LL, Rendl M, Hunter CA, Ertl HC, von Andrian UH, Weninger W. Two distinct activation states of plasmacytoid dendritic cells induced by influenza virus and CpG 1826 oligonucleotide. Journal of Leukocyte Biology. 83: 610-20. PMID 18029397 DOI: 10.1189/Jlb.0807511 |
0.593 |
|
| 2007 |
Lin SW, Hensley SE, Tatsis N, Lasaro MO, Ertl HC. Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice. The Journal of Clinical Investigation. 117: 3958-70. PMID 18008010 DOI: 10.1172/Jci33138 |
0.606 |
|
| 2007 |
Hensley SE, Amalfitano A. Toll-like receptors impact on safety and efficacy of gene transfer vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1417-22. PMID 17551505 DOI: 10.1038/Sj.Mt.6300217 |
0.319 |
|
| 2007 |
Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, Zhou D, Lin SW, Bian A, Xiang ZQ, Iparraguirre A, Lopez-Camacho C, Wherry EJ, Ertl HC. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood. 110: 1916-23. PMID 17510320 DOI: 10.1182/Blood-2007-02-062117 |
0.681 |
|
| 2007 |
McCoy K, Tatsis N, Korioth-Schmitz B, Lasaro MO, Hensley SE, Lin SW, Li Y, Giles-Davis W, Cun A, Zhou D, Xiang Z, Letvin NL, Ertl HC. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors. Journal of Virology. 81: 6594-604. PMID 17428852 DOI: 10.1128/Jvi.02497-06 |
0.646 |
|
| 2007 |
Hensley SE, Cun AS, Giles-Davis W, Li Y, Xiang Z, Lasaro MO, Williams BR, Silverman RH, Ertl HC. Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 393-403. PMID 17235319 DOI: 10.1038/Sj.Mt.6300024 |
0.586 |
|
| 2007 |
Tatsis N, Blejer A, Lasaro MO, Hensley SE, Cun A, Tesema L, Li Y, Gao GP, Xiang ZQ, Zhou D, Wilson JM, Ertl HC. A CD46-binding chimpanzee adenovirus vector as a vaccine carrier. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 608-17. PMID 17228314 DOI: 10.1038/Sj.Mt.6300078 |
0.607 |
|
| 2005 |
Hensley SE, Giles-Davis W, McCoy KC, Weninger W, Ertl HC. Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors. Journal of Immunology (Baltimore, Md. : 1950). 175: 6032-41. PMID 16237098 DOI: 10.4049/Jimmunol.175.9.6032 |
0.564 |
|
| 2004 |
Fitzgerald J, Reyes-Sandoval A, Tatsis N, Hensley SE, EH. E1-deleted adenoviral vectors persist in activated lymphocytes and cause continued transgene expression and stimulation of CD8+ effector T cells Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.625 |
0.64 |
|
| Show low-probability matches. |